United States · FDA National Drug Code directory
Guaifenesin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65162-037_f1b3934b-1fc2-4ce8-9465-e1f031daf9c5
- Product NDC
- 65162-037
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Guaifenesin
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180727
- Source listing expiry
- 20261231
Source-listed ingredients
- GUAIFENESIN — 1200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (65162-037-03) / 30 TABLET, EXTENDED RELEASE in 1 BOTTLE · 65162-037-03
- 1 BOTTLE in 1 CARTON (65162-037-06) / 60 TABLET, EXTENDED RELEASE in 1 BOTTLE · 65162-037-06
- 2 BLISTER PACK in 1 CARTON (65162-037-28) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 65162-037-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →